Furthermore, cluster 0_CD8+ TRM was prominently enriched for immune‐related pathways (Fig. S4A), suggesting a special role of tissue‐resident memory T cells in the control of solid tumors and their potential applications for treating patients with cancer [45]. Here, CD8A is linked to cancer.